Evoke Pharma (NASDAQ:EVOK) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Evoke Pharma missed estimated earnings by 18.33%, reporting an EPS of $-0.71 versus an estimate of $-0.6.
Revenue was up $225 thousand from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.36 which was followed by a 21.74% drop in the share price the next day.
Here's a look at Evoke Pharma's past performance:
|Quarter||Q1 2022||Q4 2021||Q3 2021||Q2 2021|
To track all earnings releases for Evoke Pharma visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.